Natural Product ID:   | NPC191382 |
Common Name:   | Ergotamine |
IUPAC Name:   | |
Synonyms:   | Ergotamine; Ergotamine Tartrate |
Molecular Formula:   | C33H35N5O5 |
Standard InCHIKey:   | XCGSFFUVFURLIX-VFGNJEKYSA-N |
Standard InCHI:   | InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1 |
Canonical SMILES:   | OC(=N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3 |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   | BGC0001241 ; |
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO24009 | Claviceps purpurea | Species | Clavicipitaceae | Eukaryota | TCM_Taiwan* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1784 | Individual Protein | Serotonin 5a (5-HT5a) receptor | Homo sapiens | Ki | = | 40 | nM | 12825922 |
NPT4741 | Individual Protein | Cholecystokinin A receptor | Mus musculus | IC50 | = | 34000 | nM | 10.1016/S0960-894X(00)80644-7 |
NPT4742 | Individual Protein | Cholecystokinin B receptor | Mus musculus | IC50 | = | 17000 | nM | 10.1016/S0960-894X(00)80644-7 |
NPT974 | Individual Protein | Serotonin 1d (5-HT1d) receptor | Homo sapiens | Ki | = | 0.8 | nM | 10715164 |
NPT1784 | Individual Protein | Serotonin 5a (5-HT5a) receptor | Homo sapiens | Ki | = | 22 | nM | 10715164 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | 16.7 | % | 18788725 |
NPT5074 | Individual Protein | Adenylate cyclase | Arthrospira platensis | IC50 | = | 70000 | nM | 18630896 |
NPT974 | Individual Protein | Serotonin 1d (5-HT1d) receptor | Homo sapiens | Ki | = | 6 | nM | 21907583 |
NPT1784 | Individual Protein | Serotonin 5a (5-HT5a) receptor | Homo sapiens | Ki | = | 14 | nM | 21907583 |
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | IC50 | = | 8.06 | nM | DrugMatrix in vitro pharmacology data |
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | Ki | = | 3.262 | nM | DrugMatrix in vitro pharmacology data |
NPT220 | Individual Protein | Alpha-1b adrenergic receptor | Rattus norvegicus | IC50 | = | 8.214 | nM | DrugMatrix in vitro pharmacology data |
NPT220 | Individual Protein | Alpha-1b adrenergic receptor | Rattus norvegicus | Ki | = | 4.547 | nM | DrugMatrix in vitro pharmacology data |
NPT221 | Individual Protein | Alpha-1d adrenergic receptor | Homo sapiens | IC50 | = | 49 | nM | DrugMatrix in vitro pharmacology data |
NPT221 | Individual Protein | Alpha-1d adrenergic receptor | Homo sapiens | Ki | = | 24 | nM | DrugMatrix in vitro pharmacology data |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | IC50 | = | 2.123 | nM | DrugMatrix in vitro pharmacology data |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | Ki | = | 0.796 | nM | DrugMatrix in vitro pharmacology data |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | IC50 | = | 3.844 | nM | DrugMatrix in vitro pharmacology data |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | Ki | = | 1.755 | nM | DrugMatrix in vitro pharmacology data |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | IC50 | = | 12 | nM | DrugMatrix in vitro pharmacology data |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | Ki | = | 1.809 | nM | DrugMatrix in vitro pharmacology data |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 4142 | nM | DrugMatrix in vitro pharmacology data |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 2392 | nM | DrugMatrix in vitro pharmacology data |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | IC50 | = | 2761 | nM | DrugMatrix in vitro pharmacology data |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 1898 | nM | DrugMatrix in vitro pharmacology data |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | IC50 | = | 1000 | nM | DrugMatrix in vitro pharmacology data |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | IC50 | = | 1728 | nM | DrugMatrix in vitro pharmacology data |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Ki | = | 864 | nM | DrugMatrix in vitro pharmacology data |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | IC50 | = | 4.3 | nM | DrugMatrix in vitro pharmacology data |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | Ki | = | 1.433 | nM | DrugMatrix in vitro pharmacology data |
NPT244 | Individual Protein | Dopamine D3 receptor | Homo sapiens | IC50 | = | 4.311 | nM | DrugMatrix in vitro pharmacology data |
NPT244 | Individual Protein | Dopamine D3 receptor | Homo sapiens | Ki | = | 1.464 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | IC50 | = | 3.645 | nM | DrugMatrix in vitro pharmacology data | |
NPT2 | Others | Unspecified | Ki | = | 2.43 | nM | DrugMatrix in vitro pharmacology data | |
NPT14 | Individual Protein | Tyrosine-protein kinase FYN | Homo sapiens | IC50 | = | 3160 | nM | DrugMatrix in vitro pharmacology data |
NPT13 | Individual Protein | Tyrosine-protein kinase LCK | Homo sapiens | IC50 | = | 6499 | nM | DrugMatrix in vitro pharmacology data |
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | IC50 | = | 0.774 | nM | DrugMatrix in vitro pharmacology data |
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | Ki | = | 0.443 | nM | DrugMatrix in vitro pharmacology data |
NPT289 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Rattus norvegicus | IC50 | = | 0.201 | nM | DrugMatrix in vitro pharmacology data |
NPT289 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Rattus norvegicus | Ki | = | 0.091 | nM | DrugMatrix in vitro pharmacology data |
NPT290 | Individual Protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | IC50 | = | 6.486 | nM | DrugMatrix in vitro pharmacology data |
NPT290 | Individual Protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | Ki | = | 1.853 | nM | DrugMatrix in vitro pharmacology data |
NPT291 | Individual Protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | IC50 | = | 3.461 | nM | DrugMatrix in vitro pharmacology data |
NPT291 | Individual Protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | Ki | = | 2.203 | nM | DrugMatrix in vitro pharmacology data |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | IC50 | = | 56 | nM | DrugMatrix in vitro pharmacology data |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | Ki | = | 29 | nM | DrugMatrix in vitro pharmacology data |
NPT293 | Individual Protein | Serotonin 4 (5-HT4) receptor | Cavia porcellus | IC50 | = | 1584 | nM | DrugMatrix in vitro pharmacology data |
NPT293 | Individual Protein | Serotonin 4 (5-HT4) receptor | Cavia porcellus | Ki | = | 264 | nM | DrugMatrix in vitro pharmacology data |
NPT294 | Individual Protein | Serotonin 6 (5-HT6) receptor | Homo sapiens | IC50 | = | 2.042 | nM | DrugMatrix in vitro pharmacology data |
NPT294 | Individual Protein | Serotonin 6 (5-HT6) receptor | Homo sapiens | Ki | = | 0.948 | nM | DrugMatrix in vitro pharmacology data |
NPT300 | Individual Protein | Thromboxane-A synthase | Homo sapiens | IC50 | = | 3064 | nM | DrugMatrix in vitro pharmacology data |
NPT973 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Homo sapiens | Ki | = | 2.1 | nM | 21982496 |
NPT974 | Individual Protein | Serotonin 1d (5-HT1d) receptor | Homo sapiens | Ki | = | 4.3 | nM | 21982496 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Ki | = | 98900 | nM | 11961113 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Ki | = | 14250 | nM | 11961113 |
NPT1455 | Individual Protein | P-glycoprotein 3 | Mus musculus | Ki | = | 188800 | nM | 12235267 |
NPT1456 | Individual Protein | P-glycoprotein 1 | Mus musculus | Ki | = | 18000 | nM | 12235267 |
NPT1784 | Individual Protein | Serotonin 5a (5-HT5a) receptor | Homo sapiens | Ki | = | 15.49 | nM | 24365159 |
NPT974 | Individual Protein | Serotonin 1d (5-HT1d) receptor | Homo sapiens | Ki | = | 2.63 | nM | 24365159 |
NPT973 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Homo sapiens | Ki | = | 3.02 | nM | 24365159 |
NPT1784 | Individual Protein | Serotonin 5a (5-HT5a) receptor | Homo sapiens | Ki | = | 16 | nM | 24365159 |
NPT974 | Individual Protein | Serotonin 1d (5-HT1d) receptor | Homo sapiens | Ki | = | 2.2 | nM | 24365159 |
NPT973 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Homo sapiens | Ki | = | 3.1 | nM | 24365159 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC191382 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC56109 |
0.9752 | High Similarity | NPC155444 |
0.8458 | Intermediate Similarity | NPC477714 |
0.8326 | Intermediate Similarity | NPC477715 |
0.8318 | Intermediate Similarity | NPC478157 |
0.8255 | Intermediate Similarity | NPC162860 |
0.8255 | Intermediate Similarity | NPC478158 |
0.8246 | Intermediate Similarity | NPC54420 |
0.8213 | Intermediate Similarity | NPC171317 |
0.8128 | Intermediate Similarity | NPC17059 |
0.8119 | Intermediate Similarity | NPC281049 |
0.8056 | Intermediate Similarity | NPC75634 |
0.8 | Intermediate Similarity | NPC213629 |
0.799 | Intermediate Similarity | NPC94752 |
0.798 | Intermediate Similarity | NPC228835 |
0.7917 | Intermediate Similarity | NPC107077 |
0.7917 | Intermediate Similarity | NPC223791 |
0.786 | Intermediate Similarity | NPC325976 |
0.7854 | Intermediate Similarity | NPC54744 |
0.784 | Intermediate Similarity | NPC475506 |
0.783 | Intermediate Similarity | NPC293917 |
0.7814 | Intermediate Similarity | NPC473376 |
0.7807 | Intermediate Similarity | NPC475969 |
0.7807 | Intermediate Similarity | NPC475859 |
0.7804 | Intermediate Similarity | NPC155143 |
0.7783 | Intermediate Similarity | NPC473640 |
0.7783 | Intermediate Similarity | NPC11126 |
0.7763 | Intermediate Similarity | NPC477175 |
0.7763 | Intermediate Similarity | NPC326363 |
0.7763 | Intermediate Similarity | NPC470730 |
0.7753 | Intermediate Similarity | NPC476491 |
0.7745 | Intermediate Similarity | NPC91179 |
0.7739 | Intermediate Similarity | NPC323752 |
0.7729 | Intermediate Similarity | NPC474877 |
0.7727 | Intermediate Similarity | NPC31385 |
0.7727 | Intermediate Similarity | NPC75726 |
0.7727 | Intermediate Similarity | NPC110602 |
0.7721 | Intermediate Similarity | NPC193761 |
0.7703 | Intermediate Similarity | NPC470731 |
0.7696 | Intermediate Similarity | NPC89987 |
0.7696 | Intermediate Similarity | NPC165743 |
0.7686 | Intermediate Similarity | NPC477176 |
0.7686 | Intermediate Similarity | NPC470729 |
0.7682 | Intermediate Similarity | NPC478029 |
0.7667 | Intermediate Similarity | NPC473763 |
0.7667 | Intermediate Similarity | NPC117244 |
0.7664 | Intermediate Similarity | NPC100321 |
0.7662 | Intermediate Similarity | NPC63279 |
0.7654 | Intermediate Similarity | NPC472846 |
0.7652 | Intermediate Similarity | NPC477177 |
0.7639 | Intermediate Similarity | NPC476874 |
0.7632 | Intermediate Similarity | NPC909 |
0.7632 | Intermediate Similarity | NPC319232 |
0.7632 | Intermediate Similarity | NPC24370 |
0.7632 | Intermediate Similarity | NPC475338 |
0.7629 | Intermediate Similarity | NPC297642 |
0.7623 | Intermediate Similarity | NPC470732 |
0.7621 | Intermediate Similarity | NPC64216 |
0.7613 | Intermediate Similarity | NPC475602 |
0.7598 | Intermediate Similarity | NPC475258 |
0.7597 | Intermediate Similarity | NPC478028 |
0.7574 | Intermediate Similarity | NPC194411 |
0.7571 | Intermediate Similarity | NPC321708 |
0.7561 | Intermediate Similarity | NPC68354 |
0.756 | Intermediate Similarity | NPC235684 |
0.7556 | Intermediate Similarity | NPC473310 |
0.754 | Intermediate Similarity | NPC478009 |
0.754 | Intermediate Similarity | NPC478010 |
0.7523 | Intermediate Similarity | NPC320968 |
0.7512 | Intermediate Similarity | NPC99939 |
0.7512 | Intermediate Similarity | NPC308931 |
0.75 | Intermediate Similarity | NPC315467 |
0.7489 | Intermediate Similarity | NPC471193 |
0.7489 | Intermediate Similarity | NPC471194 |
0.7489 | Intermediate Similarity | NPC6865 |
0.7489 | Intermediate Similarity | NPC153980 |
0.7477 | Intermediate Similarity | NPC475422 |
0.7466 | Intermediate Similarity | NPC87755 |
0.7465 | Intermediate Similarity | NPC47190 |
0.7464 | Intermediate Similarity | NPC165495 |
0.7463 | Intermediate Similarity | NPC37423 |
0.7463 | Intermediate Similarity | NPC275305 |
0.7456 | Intermediate Similarity | NPC474896 |
0.7453 | Intermediate Similarity | NPC95783 |
0.7449 | Intermediate Similarity | NPC314882 |
0.7444 | Intermediate Similarity | NPC72956 |
0.7435 | Intermediate Similarity | NPC19170 |
0.7429 | Intermediate Similarity | NPC15102 |
0.7426 | Intermediate Similarity | NPC472207 |
0.7424 | Intermediate Similarity | NPC312942 |
0.7424 | Intermediate Similarity | NPC31097 |
0.7424 | Intermediate Similarity | NPC327095 |
0.7414 | Intermediate Similarity | NPC297862 |
0.7412 | Intermediate Similarity | NPC272174 |
0.7407 | Intermediate Similarity | NPC227582 |
0.7403 | Intermediate Similarity | NPC472762 |
0.7398 | Intermediate Similarity | NPC478006 |
0.7397 | Intermediate Similarity | NPC476073 |
0.7393 | Intermediate Similarity | NPC63031 |
0.7391 | Intermediate Similarity | NPC59269 |
0.7391 | Intermediate Similarity | NPC40455 |
0.7389 | Intermediate Similarity | NPC472027 |
0.7385 | Intermediate Similarity | NPC252338 |
0.7382 | Intermediate Similarity | NPC69843 |
0.7378 | Intermediate Similarity | NPC473757 |
0.7356 | Intermediate Similarity | NPC126709 |
0.7356 | Intermediate Similarity | NPC248041 |
0.7356 | Intermediate Similarity | NPC283219 |
0.7352 | Intermediate Similarity | NPC300183 |
0.7348 | Intermediate Similarity | NPC253987 |
0.7342 | Intermediate Similarity | NPC477065 |
0.7339 | Intermediate Similarity | NPC74413 |
0.7336 | Intermediate Similarity | NPC153400 |
0.733 | Intermediate Similarity | NPC161861 |
0.7321 | Intermediate Similarity | NPC126066 |
0.7315 | Intermediate Similarity | NPC294693 |
0.7313 | Intermediate Similarity | NPC471192 |
0.7308 | Intermediate Similarity | NPC145885 |
0.7308 | Intermediate Similarity | NPC84827 |
0.7308 | Intermediate Similarity | NPC14113 |
0.7306 | Intermediate Similarity | NPC470497 |
0.7304 | Intermediate Similarity | NPC471506 |
0.7295 | Intermediate Similarity | NPC469938 |
0.7294 | Intermediate Similarity | NPC470499 |
0.7285 | Intermediate Similarity | NPC317701 |
0.7284 | Intermediate Similarity | NPC474196 |
0.7273 | Intermediate Similarity | NPC215795 |
0.7273 | Intermediate Similarity | NPC213468 |
0.7273 | Intermediate Similarity | NPC176199 |
0.7269 | Intermediate Similarity | NPC184225 |
0.7268 | Intermediate Similarity | NPC63751 |
0.7265 | Intermediate Similarity | NPC166492 |
0.7265 | Intermediate Similarity | NPC473362 |
0.726 | Intermediate Similarity | NPC267885 |
0.7255 | Intermediate Similarity | NPC478012 |
0.7255 | Intermediate Similarity | NPC478011 |
0.7251 | Intermediate Similarity | NPC470205 |
0.7246 | Intermediate Similarity | NPC314603 |
0.7241 | Intermediate Similarity | NPC476817 |
0.724 | Intermediate Similarity | NPC260900 |
0.7237 | Intermediate Similarity | NPC472845 |
0.7227 | Intermediate Similarity | NPC314176 |
0.7225 | Intermediate Similarity | NPC229348 |
0.7224 | Intermediate Similarity | NPC14812 |
0.722 | Intermediate Similarity | NPC49954 |
0.722 | Intermediate Similarity | NPC474561 |
0.722 | Intermediate Similarity | NPC160105 |
0.7215 | Intermediate Similarity | NPC265576 |
0.7212 | Intermediate Similarity | NPC203468 |
0.7212 | Intermediate Similarity | NPC149155 |
0.7212 | Intermediate Similarity | NPC82370 |
0.7212 | Intermediate Similarity | NPC110500 |
0.7197 | Intermediate Similarity | NPC28945 |
0.719 | Intermediate Similarity | NPC477107 |
0.719 | Intermediate Similarity | NPC219336 |
0.719 | Intermediate Similarity | NPC477108 |
0.719 | Intermediate Similarity | NPC477109 |
0.7188 | Intermediate Similarity | NPC323927 |
0.7186 | Intermediate Similarity | NPC474195 |
0.7174 | Intermediate Similarity | NPC475736 |
0.7162 | Intermediate Similarity | NPC36405 |
0.7162 | Intermediate Similarity | NPC251936 |
0.7156 | Intermediate Similarity | NPC195239 |
0.7156 | Intermediate Similarity | NPC157828 |
0.7156 | Intermediate Similarity | NPC469896 |
0.7149 | Intermediate Similarity | NPC17487 |
0.7149 | Intermediate Similarity | NPC476492 |
0.7149 | Intermediate Similarity | NPC201831 |
0.7143 | Intermediate Similarity | NPC206819 |
0.7143 | Intermediate Similarity | NPC217372 |
0.7143 | Intermediate Similarity | NPC323198 |
0.7143 | Intermediate Similarity | NPC15573 |
0.7143 | Intermediate Similarity | NPC318065 |
0.7143 | Intermediate Similarity | NPC70155 |
0.7143 | Intermediate Similarity | NPC183662 |
0.7143 | Intermediate Similarity | NPC56765 |
0.7136 | Intermediate Similarity | NPC472294 |
0.7136 | Intermediate Similarity | NPC131887 |
0.7125 | Intermediate Similarity | NPC285343 |
0.7123 | Intermediate Similarity | NPC11445 |
0.7119 | Intermediate Similarity | NPC33949 |
0.7118 | Intermediate Similarity | NPC313640 |
0.7118 | Intermediate Similarity | NPC250835 |
0.7115 | Intermediate Similarity | NPC125181 |
0.7115 | Intermediate Similarity | NPC242872 |
0.7115 | Intermediate Similarity | NPC263117 |
0.7115 | Intermediate Similarity | NPC314056 |
0.7111 | Intermediate Similarity | NPC225821 |
0.71 | Intermediate Similarity | NPC174788 |
0.7097 | Intermediate Similarity | NPC476460 |
0.7095 | Intermediate Similarity | NPC41679 |
0.7082 | Intermediate Similarity | NPC2395 |
0.708 | Intermediate Similarity | NPC258062 |
0.708 | Intermediate Similarity | NPC314957 |
0.7073 | Intermediate Similarity | NPC282231 |
0.7072 | Intermediate Similarity | NPC49196 |
0.7072 | Intermediate Similarity | NPC195461 |
0.7072 | Intermediate Similarity | NPC79129 |
0.7072 | Intermediate Similarity | NPC81654 |
0.7072 | Intermediate Similarity | NPC249150 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC191382 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD7780 | Approved |
1.0 | High Similarity | NPD7781 | Approved |
0.9522 | High Similarity | NPD7953 | Approved |
0.9522 | High Similarity | NPD7952 | Approved |
0.9522 | High Similarity | NPD7791 | Approved |
0.9522 | High Similarity | NPD7950 | Approved |
0.9522 | High Similarity | NPD7790 | Approved |
0.9522 | High Similarity | NPD7789 | Approved |
0.9522 | High Similarity | NPD7951 | Approved |
0.9282 | High Similarity | NPD7730 | Approved |
0.9282 | High Similarity | NPD7731 | Approved |
0.9194 | High Similarity | NPD7824 | Approved |
0.9187 | High Similarity | NPD7271 | Approved |
0.8957 | High Similarity | NPD7716 | Approved |
0.8957 | High Similarity | NPD7717 | Approved |
0.7991 | Intermediate Similarity | NPD8493 | Clinical (unspecified phase) |
0.7972 | Intermediate Similarity | NPD7594 | Clinical (unspecified phase) |
0.7951 | Intermediate Similarity | NPD3961 | Discontinued |
0.7844 | Intermediate Similarity | NPD7470 | Discontinued |
0.783 | Intermediate Similarity | NPD7621 | Clinical (unspecified phase) |
0.7808 | Intermediate Similarity | NPD8093 | Discontinued |
0.7748 | Intermediate Similarity | NPD8406 | Clinical (unspecified phase) |
0.7736 | Intermediate Similarity | NPD6664 | Approved |
0.7725 | Intermediate Similarity | NPD7619 | Phase 3 |
0.7725 | Intermediate Similarity | NPD7618 | Phase 3 |
0.7717 | Intermediate Similarity | NPD7998 | Clinical (unspecified phase) |
0.7713 | Intermediate Similarity | NPD8405 | Clinical (unspecified phase) |
0.7696 | Intermediate Similarity | NPD7957 | Phase 1 |
0.7696 | Intermediate Similarity | NPD7958 | Clinical (unspecified phase) |
0.7661 | Intermediate Similarity | NPD6838 | Clinical (unspecified phase) |
0.7658 | Intermediate Similarity | NPD8112 | Clinical (unspecified phase) |
0.7613 | Intermediate Similarity | NPD8094 | Discontinued |
0.761 | Intermediate Similarity | NPD4076 | Approved |
0.761 | Intermediate Similarity | NPD4079 | Approved |
0.7608 | Intermediate Similarity | NPD3486 | Clinical (unspecified phase) |
0.7602 | Intermediate Similarity | NPD8013 | Clinical (unspecified phase) |
0.7598 | Intermediate Similarity | NPD4075 | Phase 2 |
0.7593 | Intermediate Similarity | NPD7903 | Clinical (unspecified phase) |
0.7589 | Intermediate Similarity | NPD8000 | Clinical (unspecified phase) |
0.7585 | Intermediate Similarity | NPD5728 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD6203 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD3505 | Approved |
0.7561 | Intermediate Similarity | NPD3506 | Approved |
0.7559 | Intermediate Similarity | NPD7944 | Discontinued |
0.7557 | Intermediate Similarity | NPD7809 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7970 | Approved |
0.75 | Intermediate Similarity | NPD7971 | Clinical (unspecified phase) |
0.7489 | Intermediate Similarity | NPD5426 | Phase 3 |
0.7466 | Intermediate Similarity | NPD7947 | Clinical (unspecified phase) |
0.7441 | Intermediate Similarity | NPD8431 | Approved |
0.7429 | Intermediate Similarity | NPD6610 | Clinical (unspecified phase) |
0.7409 | Intermediate Similarity | NPD8272 | Phase 2 |
0.7403 | Intermediate Similarity | NPD7711 | Discontinued |
0.7342 | Intermediate Similarity | NPD8322 | Phase 2 |
0.7339 | Intermediate Similarity | NPD6661 | Clinical (unspecified phase) |
0.7336 | Intermediate Similarity | NPD6180 | Clinical (unspecified phase) |
0.733 | Intermediate Similarity | NPD8114 | Approved |
0.733 | Intermediate Similarity | NPD8115 | Approved |
0.733 | Intermediate Similarity | NPD7712 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD7603 | Discontinued |
0.7318 | Intermediate Similarity | NPD8073 | Approved |
0.7318 | Intermediate Similarity | NPD5721 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD4181 | Approved |
0.7295 | Intermediate Similarity | NPD4128 | Approved |
0.7291 | Intermediate Similarity | NPD3583 | Phase 2 |
0.7291 | Intermediate Similarity | NPD3323 | Discontinued |
0.7285 | Intermediate Similarity | NPD8072 | Approved |
0.7277 | Intermediate Similarity | NPD8317 | Phase 2 |
0.7277 | Intermediate Similarity | NPD8316 | Phase 2 |
0.726 | Intermediate Similarity | NPD6375 | Clinical (unspecified phase) |
0.7253 | Intermediate Similarity | NPD8289 | Discontinued |
0.7251 | Intermediate Similarity | NPD2094 | Phase 2 |
0.7251 | Intermediate Similarity | NPD2095 | Phase 2 |
0.7251 | Intermediate Similarity | NPD2092 | Phase 2 |
0.7249 | Intermediate Similarity | NPD6578 | Clinical (unspecified phase) |
0.723 | Intermediate Similarity | NPD4426 | Clinical (unspecified phase) |
0.7217 | Intermediate Similarity | NPD2096 | Phase 2 |
0.7217 | Intermediate Similarity | NPD2091 | Phase 2 |
0.7217 | Intermediate Similarity | NPD7482 | Phase 2 |
0.7217 | Intermediate Similarity | NPD7483 | Phase 2 |
0.7212 | Intermediate Similarity | NPD482 | Approved |
0.7205 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7203 | Intermediate Similarity | NPD7688 | Phase 1 |
0.7195 | Intermediate Similarity | NPD7727 | Phase 2 |
0.7184 | Intermediate Similarity | NPD4640 | Approved |
0.7184 | Intermediate Similarity | NPD4639 | Approved |
0.7184 | Intermediate Similarity | NPD4638 | Approved |
0.7177 | Intermediate Similarity | NPD749 | Clinical (unspecified phase) |
0.7173 | Intermediate Similarity | NPD8119 | Discontinued |
0.7171 | Intermediate Similarity | NPD5744 | Clinical (unspecified phase) |
0.7163 | Intermediate Similarity | NPD7233 | Approved |
0.7163 | Intermediate Similarity | NPD7234 | Approved |
0.7163 | Intermediate Similarity | NPD8110 | Clinical (unspecified phase) |
0.7156 | Intermediate Similarity | NPD8464 | Clinical (unspecified phase) |
0.7156 | Intermediate Similarity | NPD6595 | Phase 3 |
0.7156 | Intermediate Similarity | NPD7666 | Phase 3 |
0.7156 | Intermediate Similarity | NPD7665 | Phase 2 |
0.7155 | Intermediate Similarity | NPD6615 | Clinical (unspecified phase) |
0.7149 | Intermediate Similarity | NPD8248 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4862 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD2144 | Approved |
0.7143 | Intermediate Similarity | NPD7001 | Phase 3 |
0.7143 | Intermediate Similarity | NPD5040 | Clinical (unspecified phase) |
0.7136 | Intermediate Similarity | NPD3607 | Clinical (unspecified phase) |
0.7136 | Intermediate Similarity | NPD7564 | Discontinued |
0.713 | Intermediate Similarity | NPD8271 | Discontinued |
0.713 | Intermediate Similarity | NPD5487 | Phase 1 |
0.7124 | Intermediate Similarity | NPD5835 | Phase 3 |
0.7124 | Intermediate Similarity | NPD5834 | Phase 3 |
0.7123 | Intermediate Similarity | NPD3038 | Discontinued |
0.7104 | Intermediate Similarity | NPD7000 | Clinical (unspecified phase) |
0.7104 | Intermediate Similarity | NPD6999 | Discontinued |
0.7104 | Intermediate Similarity | NPD6249 | Phase 2 |
0.7104 | Intermediate Similarity | NPD6248 | Phase 2 |
0.7101 | Intermediate Similarity | NPD4779 | Clinical (unspecified phase) |
0.7098 | Intermediate Similarity | NPD5901 | Discontinued |
0.7097 | Intermediate Similarity | NPD6630 | Clinical (unspecified phase) |
0.7093 | Intermediate Similarity | NPD6204 | Clinical (unspecified phase) |
0.7093 | Intermediate Similarity | NPD7825 | Clinical (unspecified phase) |
0.709 | Intermediate Similarity | NPD7921 | Approved |
0.7081 | Intermediate Similarity | NPD750 | Phase 2 |
0.7078 | Intermediate Similarity | NPD7024 | Clinical (unspecified phase) |
0.7072 | Intermediate Similarity | NPD4601 | Approved |
0.7072 | Intermediate Similarity | NPD4600 | Approved |
0.707 | Intermediate Similarity | NPD6217 | Discontinued |
0.7067 | Intermediate Similarity | NPD4184 | Clinical (unspecified phase) |
0.7064 | Intermediate Similarity | NPD6665 | Discontinued |
0.7059 | Intermediate Similarity | NPD7393 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD8372 | Clinical (unspecified phase) |
0.7056 | Intermediate Similarity | NPD8257 | Approved |
0.7056 | Intermediate Similarity | NPD8258 | Clinical (unspecified phase) |
0.7056 | Intermediate Similarity | NPD8256 | Approved |
0.7051 | Intermediate Similarity | NPD6281 | Approved |
0.7045 | Intermediate Similarity | NPD7818 | Clinical (unspecified phase) |
0.704 | Intermediate Similarity | NPD7817 | Phase 1 |
0.704 | Intermediate Similarity | NPD5017 | Discontinued |
0.7031 | Intermediate Similarity | NPD8458 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD8488 | Clinical (unspecified phase) |
0.6996 | Remote Similarity | NPD6479 | Discontinued |
0.6995 | Remote Similarity | NPD6277 | Clinical (unspecified phase) |
0.6979 | Remote Similarity | NPD6995 | Phase 1 |
0.6972 | Remote Similarity | NPD4499 | Approved |
0.6968 | Remote Similarity | NPD6449 | Clinical (unspecified phase) |
0.6967 | Remote Similarity | NPD5065 | Approved |
0.6959 | Remote Similarity | NPD6141 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD7573 | Discontinued |
0.6944 | Remote Similarity | NPD7772 | Phase 3 |
0.6943 | Remote Similarity | NPD4900 | Clinical (unspecified phase) |
0.6942 | Remote Similarity | NPD8279 | Clinical (unspecified phase) |
0.6937 | Remote Similarity | NPD7948 | Phase 1 |
0.6933 | Remote Similarity | NPD6978 | Phase 2 |
0.6933 | Remote Similarity | NPD6977 | Clinical (unspecified phase) |
0.693 | Remote Similarity | NPD2509 | Approved |
0.693 | Remote Similarity | NPD2510 | Approved |
0.6923 | Remote Similarity | NPD4602 | Approved |
0.692 | Remote Similarity | NPD6976 | Clinical (unspecified phase) |
0.6912 | Remote Similarity | NPD5809 | Phase 3 |
0.6904 | Remote Similarity | NPD5559 | Phase 2 |
0.6901 | Remote Similarity | NPD8329 | Phase 3 |
0.69 | Remote Similarity | NPD8524 | Approved |
0.69 | Remote Similarity | NPD2125 | Clinical (unspecified phase) |
0.6883 | Remote Similarity | NPD7455 | Approved |
0.6883 | Remote Similarity | NPD7454 | Approved |
0.6872 | Remote Similarity | NPD3609 | Approved |
0.6872 | Remote Similarity | NPD3610 | Approved |
0.6867 | Remote Similarity | NPD7543 | Phase 2 |
0.6867 | Remote Similarity | NPD8523 | Approved |
0.6865 | Remote Similarity | NPD8246 | Approved |
0.6865 | Remote Similarity | NPD8247 | Approved |
0.6864 | Remote Similarity | NPD8240 | Discontinued |
0.6862 | Remote Similarity | NPD6164 | Phase 2 |
0.6862 | Remote Similarity | NPD6165 | Phase 2 |
0.6861 | Remote Similarity | NPD6206 | Phase 1 |
0.6858 | Remote Similarity | NPD7187 | Phase 2 |
0.6849 | Remote Similarity | NPD7175 | Phase 1 |
0.6849 | Remote Similarity | NPD6965 | Clinical (unspecified phase) |
0.6847 | Remote Similarity | NPD4427 | Phase 2 |
0.6842 | Remote Similarity | NPD6732 | Clinical (unspecified phase) |
0.684 | Remote Similarity | NPD4112 | Clinical (unspecified phase) |
0.684 | Remote Similarity | NPD8349 | Phase 1 |
0.684 | Remote Similarity | NPD4614 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD5820 | Clinical (unspecified phase) |
0.6833 | Remote Similarity | NPD4922 | Phase 2 |
0.6829 | Remote Similarity | NPD7576 | Discontinued |
0.6828 | Remote Similarity | NPD2121 | Clinical (unspecified phase) |
0.6827 | Remote Similarity | NPD8250 | Phase 2 |
0.682 | Remote Similarity | NPD6178 | Phase 3 |
0.6808 | Remote Similarity | NPD5322 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD6753 | Phase 1 |
0.6807 | Remote Similarity | NPD6173 | Approved |
0.6807 | Remote Similarity | NPD6752 | Phase 1 |
0.6805 | Remote Similarity | NPD8374 | Phase 3 |
0.68 | Remote Similarity | NPD7308 | Discontinued |
0.68 | Remote Similarity | NPD3800 | Clinical (unspecified phase) |
0.6797 | Remote Similarity | NPD4051 | Discontinued |
0.6795 | Remote Similarity | NPD3394 | Approved |
0.6795 | Remote Similarity | NPD3393 | Approved |
0.6795 | Remote Similarity | NPD3389 | Approved |
0.6792 | Remote Similarity | NPD8430 | Approved |
0.679 | Remote Similarity | NPD7415 | Suspended |
Molecular Weight:   | 581.26 |
ALogP:   | -1.9682 |
MLogP:   | 3.99 |
XLogP:   | 4.003 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 121.7 |
# H-Bond Aceptor:   | 10 |
# H-Bond Donor:   | 3 |
# Rings:   | 8 |
# Heavy Atoms:   | 43 |